China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $2.18 million. The enterprise value is -$6.20 million.
Market Cap | 2.18M |
Enterprise Value | -6.20M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
SXTC has 434,511 shares outstanding. The number of shares has increased by 224.91% in one year.
Current Share Class | 434,511 |
Shares Outstanding | 434,511 |
Shares Change (YoY) | +224.91% |
Shares Change (QoQ) | +145.96% |
Owned by Insiders (%) | 0.97% |
Owned by Institutions (%) | 2.40% |
Float | 3.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.38 |
Forward PS | n/a |
PB Ratio | 0.13 |
P/TBV Ratio | 0.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.27.
Current Ratio | 1.60 |
Quick Ratio | 1.51 |
Debt / Equity | 0.27 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.78 |
Financial Efficiency
Return on equity (ROE) is -21.65% and return on invested capital (ROIC) is -6.34%.
Return on Equity (ROE) | -21.65% |
Return on Assets (ROA) | -4.96% |
Return on Invested Capital (ROIC) | -6.34% |
Return on Capital Employed (ROCE) | -14.71% |
Revenue Per Employee | $25,713 |
Profits Per Employee | -$41,314 |
Employee Count | 75 |
Asset Turnover | 0.07 |
Inventory Turnover | 1.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.40% in the last 52 weeks. The beta is 1.04, so SXTC's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | -65.40% |
50-Day Moving Average | 3.39 |
200-Day Moving Average | 5.78 |
Relative Strength Index (RSI) | 61.88 |
Average Volume (20 Days) | 254,149 |
Short Selling Information
Short Interest | 94,124 |
Short Previous Month | 41,077 |
Short % of Shares Out | 2.40% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, SXTC had revenue of $1.93 million and -$3.10 million in losses. Loss per share was -$28.58.
Revenue | 1.93M |
Gross Profit | 553,971 |
Operating Income | -2.09M |
Pretax Income | -14.14M |
Net Income | -3.10M |
EBITDA | -1.89M |
EBIT | -2.09M |
Loss Per Share | -$28.58 |
Balance Sheet
The company has $12.07 million in cash and $3.70 million in debt, giving a net cash position of $8.38 million or $19.28 per share.
Cash & Cash Equivalents | 12.07M |
Total Debt | 3.70M |
Net Cash | 8.38M |
Net Cash Per Share | $19.28 |
Equity (Book Value) | 13.93M |
Book Value Per Share | 50.24 |
Working Capital | 5.33M |
Cash Flow
In the last 12 months, operating cash flow was -$1.93 million and capital expenditures -$7,063, giving a free cash flow of -$1.94 million.
Operating Cash Flow | -1.93M |
Capital Expenditures | -7,063 |
Free Cash Flow | -1.94M |
FCF Per Share | -$4.45 |
Margins
Gross margin is 28.73%, with operating and profit margins of -108.49% and -160.67%.
Gross Margin | 28.73% |
Operating Margin | -108.49% |
Pretax Margin | -160.67% |
Profit Margin | -160.67% |
EBITDA Margin | -97.95% |
EBIT Margin | -108.49% |
FCF Margin | n/a |
Dividends & Yields
SXTC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -224.91% |
Shareholder Yield | -224.91% |
Earnings Yield | -142.34% |
FCF Yield | -88.89% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 5, 2023. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Oct 5, 2023 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
SXTC has an Altman Z-Score of -1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.32 |
Piotroski F-Score | 5 |